Suchen
Elanco Animal Health Inc
ELANZur Watchlist hinzufügen
22.420USD
-0.320-1.41%
Handelsschluss 09-17 16:00（ET）
11.20BMarktkapitalisierung
VerlustKGV TTM
Nachbörsliches Trading 16:10 (ET)22.420USD+0.025+0.11%
Nachbörsliches Trading 16:10 (ET)mehr Informationen über Elanco Animal Health Inc Unternehmen
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Inc Profil
BörsenkürzelELAN
Name des UnternehmensElanco Animal Health Inc
IPO-datumSep 20, 2018
CEOSimmons (Jeffrey N)
Anzahl der mitarbeiter9000
WertpapierartOrdinary Share
GeschäftsjahresendeSep 20
Addresse450 Elanco Circle
StadtINDIANAPOLIS
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl46221
Telefon18773526261
Websitehttps://www.elanco.com/
BörsenkürzelELAN
IPO-datumSep 20, 2018
CEOSimmons (Jeffrey N)
Führungskräfte von Elanco Animal Health Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
227.21K
+17.60%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
227.21K
+17.60%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
227.21K
+17.60%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Center of Strategic Growth
Executive Vice President - Center of Strategic Growth
158.49K
+49.27%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Elanco Animal Health Inc?
Die fünf größten Anteilseigner von Elanco Animal Health Inc sind: Mr. Jeffrey N. (Jeff) Simmons
Wie viele Institutionen halten Anteile an Elanco Animal Health Inc (ELAN)?
Mit Stand vom 2026Q1 halten 950 Institutionen Anteile an Elanco Animal Health Inc, mit einem Gesamtmarktwert von etwa 549.30M, was 109.98% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -60070109.00 gestiegen.
Was ist die größte Einnahmequelle von Elanco Animal Health Inc?
Am 2026Q1 erzielte das Geschäft mit Pet Health für Elanco Animal Health Inc den höchsten Umsatz in Höhe von 718.00M, was 52.49% des Gesamtumsatzes entspricht.